Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-seq analysis of human non-transformed breast epithelial cell lines MCF10A with ARID1A knockdown

ABSTRACT: We performed ChIP-Seq analysis for the binding of ARID1A abundance genome-wide. These studies were performed in MCF10A, the human non-transformed breast epithelial cell line, with ARID1A knockdown and control group.

ORGANISM(S): Homo sapiens

PROVIDER: GSE169442 | GEO | 2022/12/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

ChIP-seq analysis of human non-transformed breast epithelial cell lines MCF10A with ARID1A knockdown

Project description:ChIP-seq analysis of human non-transformed breast epithelial cell lines MCF10A with ARID1A knockdown

| PRJNA716617 | ENA

Gene expression changes in human non-transformed breast epithelial cell lines with ARID1A knockdown.

Project description:We measured changes in gene expression using human non-transformed breast epithelial cell lines with ARID1A knockdown.

2023-01-01 | GSE158694 | GEO

Gene expression changes in human non-transformed breast epithelial cell lines with ARID1A knockdown.

Project description:Gene expression changes in human non-transformed breast epithelial cell lines with ARID1A knockdown.

| PRJNA666204 | ENA

Gene expression data ARID1A knockdown OE33 cells versus mock OE33 cells

Project description:A nonsense mutation in ARID1A was identified by next generation sequencing in non-dysplastic Barrett's esophagus [BE] tissue and esophageal adenocarcinoma [EAC] tissue of a patient diagnosed with EAC. Immunohistochemistry performed on an independent archival cohort demonstrated ARID1A protein loss in 0% (0/76), 4.9% (2/40), 14.3% (4/28), 16.0% (8/50), and 12.2% (12/98) of normal squamous epithelium, BE, low-, high-grade dysplasia, and EAC tissues, respectively. Enhanced cell growth, proliferation and invasion were observed upon ARID1A knockdown in EAC cells. ARID1A was knocked down in OE33 cells (Sample MS_1 and MS_3) using on-TARGET smartpool ARID1A siRNA. At the same time, OE33 cells were transfected with a non-targeting siRNA, and these experiments (Samples MS_2 and MS_4) functioned as mock controls. Cells were harvested after 48 hours and total RNA was extracted using the Rneasy kit (Qiagen) Aim Affymetrix Human PrimeView Gene Expression Array : to determine the downstream effectors of ARID1A that are likely to contribute to the oncogenic phenotype caused by ARID1A down-regulation. Two biological replicates of each condition (2x ARID1A knockdown, and 2x Mock) were used for the microarray experiment.

2012-05-31 | E-GEOD-38380 | biostudies-arrayexpress

mRNA-seq for HCT116 Parental and ARID1A knockdown cells, mRNA-seq for DLD1 Parental, ARID1A knockdown and ARID1A knockout cells, mRNA-seq for COLO320DM Parental and ARID1A knockdown and ARID1A knockout cells

Project description:The study identifies genes that are regulated by the loss of the chromatin remodeller subunit ARID1A in colorectal cancer cell lines. This gene is frequently mutated in colorectal cancer.

2019-06-11 | E-MTAB-7791 | biostudies-arrayexpress

Expression analysis of genes responding to ARID1A knockdown

Project description:Illumina array was employed to analyze the genes whose expression are altered when ARID1A gene is downregulated by shRNA in normal ovarian surface epithelial cells OSE4 and IOSE80pc. This leads to discovery of p53-regulated genes such as p21 and SMAD3. ARID1A knockdown in OSE4 and IOSE80pc

2012-05-01 | E-GEOD-37684 | biostudies-arrayexpress

Knockdown and overexpression of SLC3A2 in MCF10A cells

Project description:To knock down SLC3A2, MCF10A cells were either transfected with control siRNAs, or siRNAs specifically targetting SLC3A2. Samples were either untreated or treated with TGFb. Ribosome profiling and RNA sequencing was performed on these samples. MCF10A cells with and without SLC3A2 overexpression construct were either untreated or treated with TGFb. Ribosome profiling was performed on these samples.

2017-07-27 | GSE59818 | GEO

Development of gene expression signatures for MCF10A cell lines carrying HER2 and WT or H1047R PIK3CA oncogenes.

Project description:We wanted to know how introduction of H1047R oncogenic mutation of PIK3CA (p110a subunit of PI3K) in HER2-overexpressing MCF10A human non-transformed mammary epitheial cell lines introduces change in gene expression levels. Our control was HER2-overexpressing MCF10A cell line with wild-type (WT) PIK3CA. Mutated oncogene-induced gene expression signature was measured and compared with that induced by the WT oncogene from cell lines harvested at 70-80% confluency.

2021-03-16 | GSE117389 | GEO

Time-course transcriptomic profiling of cell-cycle entry in MCF10A cells

Project description:To identify potential novel regulators of G1/S transition and S-phase progression, we performed an RNA sequencing (RNA-Seq) time-course analysis of non-transformed human breast epithelial cells (MCF10A) released into the cell cycle from serum starvation, in the presence of DMSO or a specific CDK4/6 inhibitor palbociclib.

2021-04-29 | GSE173509 | GEO

Effects of ARID1A knockdown on gene expression in human cholangiocyte cell line MMNK1

Project description:To explore transcriptomic mechanisms underlying the proliferative, dedifferentiated phenotypes observed in ARID1A knockdown MMNK1 cell, We performed RNA-seq analysis on MMNK1 cells infected with sh-ARID1A versus sh-Scramble lentiviruses

2022-09-05 | GSE207892 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data